Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intranasal Delivery of NEMO-Binding Domain Peptide Prevents Memory Loss in a Mouse Model of Alzheimer’s Disease
Suresh B. Rangasamy, Grant T. Corbett, Avik Roy, et al.
Journal of Alzheimer s Disease (2015) Vol. 47, Iss. 2, pp. 385-402
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Religious Orders Study and Rush Memory and Aging Project
David A. Bennett, Aron S. Buchman, Patricia A. Boyle, et al.
Journal of Alzheimer s Disease (2018) Vol. 64, Iss. s1, pp. S161-S189
Open Access | Times Cited: 1020
Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs
Mukta Agrawal, Swarnlata Saraf, Shailendra Saraf, et al.
Journal of Controlled Release (2018) Vol. 281, pp. 139-177
Closed Access | Times Cited: 500
Selective targeting of the TLR2/MyD88/NF-κB pathway reduces α-synuclein spreading in vitro and in vivo
Debashis Dutta, Malabendu Jana, Moumita Majumder, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 124
Nose-to-brain peptide delivery – The potential of nanotechnology
Eleni Samaridou, Marı́a José Alonso
Bioorganic & Medicinal Chemistry (2017) Vol. 26, Iss. 10, pp. 2888-2905
Closed Access | Times Cited: 146
Suppression of gut dysbiosis by Bifidobacterium longum alleviates cognitive decline in 5XFAD transgenic and aged mice
Hae-Ji Lee, Kyung‐Eon Lee, Jeon-Kyung Kim, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 126
Selective disruption of TLR2-MyD88 interaction inhibits inflammation and attenuates Alzheimer’s pathology
Suresh B. Rangasamy, Malabendu Jana, Avik Roy, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 10, pp. 4297-4312
Open Access | Times Cited: 119
Aspirin Induces Lysosomal Biogenesis and Attenuates Amyloid Plaque Pathology in a Mouse Model of Alzheimer's Disease via PPARα
Sujyoti Chandra, Malabendu Jana, Kalipada Pahan
Journal of Neuroscience (2018) Vol. 38, Iss. 30, pp. 6682-6699
Open Access | Times Cited: 118
Tau fibrils induce glial inflammation and neuropathology via TLR2 in Alzheimer’s disease–related mouse models
Debashis Dutta, Malabendu Jana, Ramesh Kumar Paidi, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 18
Open Access | Times Cited: 39
Aspirin binds to PPARα to stimulate hippocampal plasticity and protect memory
Dhruv R. Patel, Avik Roy, Madhuchhanda Kundu, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 31
Open Access | Times Cited: 77
Sepsis: developing new alternatives to reduce neuroinflammation and attenuate brain injury
Gabriela Meneses, Graciela Cárdenas, Alejandro Espinosa, et al.
Annals of the New York Academy of Sciences (2018) Vol. 1437, Iss. 1, pp. 43-56
Closed Access | Times Cited: 66
Lactobacillus plantarum C29‐Fermented Soybean (DW2009) Alleviates Memory Impairment in 5XFAD Transgenic Mice by Regulating Microglia Activation and Gut Microbiota Composition
Hae‐Ji Lee, Yun‐Ha Hwang, Dong‐Hyun Kim
Molecular Nutrition & Food Research (2018) Vol. 62, Iss. 20
Closed Access | Times Cited: 64
The Potential Benefits of Nanotechnology in Treating Alzheimer’s Disease
Tan Sook Ling, Shanthini Chandrasegaran, Zhi Xuan Low, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-9
Open Access | Times Cited: 44
Activation of PPARα enhances astroglial uptake and degradation of β-amyloid
Sumita Raha, Arunava Ghosh, Debashis Dutta, et al.
Science Signaling (2021) Vol. 14, Iss. 706
Open Access | Times Cited: 43
Angiotensin Converting Enzyme Inhibitors Ameliorate Brain Inflammation Associated with Microglial Activation: Possible Implications for Alzheimer’s Disease
Nofar Torika, Keren Asraf, Ella Roasso, et al.
Journal of Neuroimmune Pharmacology (2016) Vol. 11, Iss. 4, pp. 774-785
Closed Access | Times Cited: 57
Peptides as Potential Therapeutics for Alzheimer’s Disease
Samo Ribarič
Molecules (2018) Vol. 23, Iss. 2, pp. 283-283
Open Access | Times Cited: 53
Gypenosides reverses depressive behavior via inhibiting hippocampal neuroinflammation
Shuqi Dong, Qiuping Zhang, Ji‐Xiao Zhu, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 106, pp. 1153-1160
Closed Access | Times Cited: 49
Gemfibrozil, a Lipid-Lowering Drug, Lowers Amyloid Plaque Pathology and Enhances Memory in a Mouse Model of Alzheimer’s Disease via Peroxisome Proliferator-Activated Receptor α
Sujyoti Chandra, Kalipada Pahan
Journal of Alzheimer s Disease Reports (2019) Vol. 3, Iss. 1, pp. 149-168
Open Access | Times Cited: 43
Nebulization of low-dose aspirin ameliorates Huntington’s pathology in N171-82Q transgenic mice
Susanta Mondal, Shelby Prieto, Suresh B. Rangasamy, et al.
NeuroImmune Pharmacology and Therapeutics (2024) Vol. 3, Iss. 1, pp. 47-59
Open Access | Times Cited: 5
Intranasal Peptide Therapeutics: A Promising Avenue for Overcoming the Challenges of Traditional CNS Drug Development
Meenakshi Bose, Gabriela Farias Quipildor, Michelle E. Ehrlich, et al.
Cells (2022) Vol. 11, Iss. 22, pp. 3629-3629
Open Access | Times Cited: 20
Intranasal delivery of biotechnology-based therapeutics
Dhrumi Patel, Bharvi Patel, Sarika Wairkar
Drug Discovery Today (2022) Vol. 27, Iss. 12, pp. 103371-103371
Closed Access | Times Cited: 18
Protein and peptide delivery through respiratory pathway
Hemal Tandel, Kiruba Florence, Mitali Upadhyay, et al.
Elsevier eBooks (2025), pp. 227-286
Closed Access
The aggregation tendencies of the signal peptide regions of prone and not prone to aggregate proteins
N. Horgan, Anabela Djurovic-Topalovic, Taiwo A. Ademoye, et al.
Biochemistry and Biophysics Reports (2025) Vol. 42, pp. 101980-101980
Closed Access
Autofluorescence cascade nanozyme catalyzes in vivo ROS scavenging for precisive anti-neuroinflammation therapy
Xiyu Du, Gang Zhao, Yifei Fu, et al.
Chemical Engineering Journal (2025), pp. 163217-163217
Closed Access
A nuclear factor-kappa B inhibiting peptide suppresses innate immune receptors and gliosis in a transgenic mouse model of Alzheimer’s disease
Alison K. Lindsay, Deborah Hickman, Mythily Srinivasan
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111405-111405
Open Access | Times Cited: 21
Treadmill workout activates PPARα in the hippocampus to upregulate ADAM10, decrease plaques and improve cognitive functions in 5XFAD mouse model of Alzheimer’s disease
Suresh B. Rangasamy, Malabendu Jana, Sridevi Dasarathi, et al.
Brain Behavior and Immunity (2023) Vol. 109, pp. 204-218
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top